Search research articles
Contact Us
Filters
Showing results (111-120 of 303) with videos related to
Page
of 31
Sort By:
Advances in Second Messenger and Phosphoprotein Research
|
January 1, 1997
The pseudosubstrate sequences alone are not sufficient for potent autoinhibition of cAMP- and cGMP-dependent protein kinases as determined by synthetic peptide analysis
C E Poteet-Smith, J D Corbin, S H Francis
The Mount Sinai Journal of Medicine, New York
|
November 1, 1995
Central neurocytoma: An unusual intraventricular tumor
S P Molinari, K Sivakumar, D Corbin, et al.
Journal of Bacteriology
|
February 20, 2007
Interaction between cell division proteins FtsE and FtsZ
Brian D Corbin, Yipeng Wang, Tushar K Beuria, et al.
The Journal of Biological Chemistry
|
November 15, 1990
The absence of a m7G cap on beta-globin mRNA and alfalfa mosaic virus RNA 4 increases the amounts of initiation factor 4F required for translation
L Fletcher, S D Corbin, K S Browning, et al.
The American Journal of Cardiology
|
March 17, 1999
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
R M Wallis, J D Corbin, S H Francis, et al.
The Journal of Biological Chemistry
|
March 25, 1984
Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes
S J Beebe, R Holloway, S R Rannels, et al.
The Journal of Biological Chemistry
|
December 25, 1991
Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity
J B Shabb, B D Buzzeo, L Ng, et al.
Second Messengers and Phosphoproteins
|
January 1, 1988
Types I alpha and I beta isozymes of cGMP-dependent protein kinase: alternative mRNA splicing may produce different inhibitory domains
S H Francis, T A Woodford, L Wolfe, et al.
Neurochemistry International
|
August 18, 2004
Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)
Jackie D Corbin, Alfreda Beasley, Mitsi A Blount, et al.
The Journal of Biological Chemistry
|
January 29, 2005
Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation
Roya Zoraghi, Emmanuel P Bessay, Jackie D Corbin, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 303) with videos related to
Sort By:
Page
of 31
Advances in Second Messenger and Phosphoprotein Research
|
January 1, 1997
The pseudosubstrate sequences alone are not sufficient for potent autoinhibition of cAMP- and cGMP-dependent protein kinases as determined by synthetic peptide analysis
C E Poteet-Smith, J D Corbin, S H Francis
The Mount Sinai Journal of Medicine, New York
|
November 1, 1995
Central neurocytoma: An unusual intraventricular tumor
S P Molinari, K Sivakumar, D Corbin, et al.
Journal of Bacteriology
|
February 20, 2007
Interaction between cell division proteins FtsE and FtsZ
Brian D Corbin, Yipeng Wang, Tushar K Beuria, et al.
The Journal of Biological Chemistry
|
November 15, 1990
The absence of a m7G cap on beta-globin mRNA and alfalfa mosaic virus RNA 4 increases the amounts of initiation factor 4F required for translation
L Fletcher, S D Corbin, K S Browning, et al.
The American Journal of Cardiology
|
March 17, 1999
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
R M Wallis, J D Corbin, S H Francis, et al.
The Journal of Biological Chemistry
|
March 25, 1984
Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes
S J Beebe, R Holloway, S R Rannels, et al.
The Journal of Biological Chemistry
|
December 25, 1991
Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity
J B Shabb, B D Buzzeo, L Ng, et al.
Second Messengers and Phosphoproteins
|
January 1, 1988
Types I alpha and I beta isozymes of cGMP-dependent protein kinase: alternative mRNA splicing may produce different inhibitory domains
S H Francis, T A Woodford, L Wolfe, et al.
Neurochemistry International
|
August 18, 2004
Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)
Jackie D Corbin, Alfreda Beasley, Mitsi A Blount, et al.
The Journal of Biological Chemistry
|
January 29, 2005
Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation
Roya Zoraghi, Emmanuel P Bessay, Jackie D Corbin, et al.
Page
of 31